HAS
30
2
EL
20
3
IP
70
2
MA
55
-7
AMGN
44
5
XEL
67
2
DAL
80
-4
TDC
75
4
HCP
58
4
EQIX
60
-2
JPM
63
-4
ZTS
47
2
WDC
41
-2
JWN
40
-2
IFF
53
2
SO
55
-2
EXPE
88
2
ABT
57
-5
INTC
35
-2
PRU
57
-3
HAS
30
2
EL
20
3
IP
70
2
MA
55
-7
AMGN
44
5
XEL
67
2
DAL
80
-4
TDC
75
4
HCP
58
4
EQIX
60
-2
JPM
63
-4
ZTS
47
2
WDC
41
-2
JWN
40
-2
IFF
53
2
SO
55
-2
EXPE
88
2
ABT
57
-5
INTC
35
-2
PRU
57
-3
Financhill
Back

Repligen Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

RGEN
Repligen

Last Price:
141.70
Seasonality Move:
11.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Repligen Stock Forecast

  • Over the next 52 weeks, Repligen has on average historically risen by 19.2% based on the past 38 years of stock performance.
  • Repligen has risen higher in 20 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
  • Is Repligen Stock Undervalued?
    The current Repligen [RGEN] share price is $138.90. The Score for RGEN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Repligen Stock Go Up Next Year?

  • Over the next 52 weeks, Repligen has on average historically risen by 19.2% based on the past 38 years of stock performance.

Repligen Stock Rating

Sell
45
Repligen (RGEN) is a Sell

Is Repligen overpriced?

  • Repligen has risen higher in 20 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Repligen Stock Price History

Is RGEN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGEN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com

52-Week Data

52-Week High:
211.13
52-Week Low:
113.50

Prediction Charts

Market Cap:
7.78B
Price in USD:
138.90
Volume:
816.4K
Beta:
0.97

Technical Analysis

SMA50:
140.24
SMA100:
141.93
SMA200:
156.61
52-Wk Change:
-10.76%

Stock Predictions

  • Is Repligen stock public?
    Yes, Repligen is a publicly traded company.
  • What is the Repligen stock quote today?
    The Repligen stock price is 138.90 USD today.
  • How to buy Repligen stock online?
    You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 134.27 138.61 138.79 134.27
Nov-4 138.64 139.67 140.74 136.41
Nov-5 138.32 145.95 146.03 138.32
Nov-6 150.10 145.93 150.78 141.00
Nov-7 145.26 143.88 146.35 142.95
Nov-8 143.04 140.64 143.27 140.00
Nov-11 140.80 139.51 141.83 137.27
Nov-12 147.50 148.59 154.48 145.00
Nov-13 144.96 150.43 154.32 143.95
Nov-14 148.58 142.43 149.88 142.08
Nov-15 140.87 124.73 141.17 121.52
Nov-18 125.10 123.41 126.25 122.02
Nov-19 121.53 128.49 128.98 121.53
Nov-20 129.58 138.90 139.20 128.53

Repligen Earnings

Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.

Repligen Forecast Revenue Growth

Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.